Technical Analysis for TVTX - Travere Therapeutics, Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
F | 5.45 | -5.05% | -0.29 |
TVTX closed down 5.05 percent on Wednesday, April 24, 2024, on 2.21 times normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
Earnings due: May 2
*** please verify all earnings dates ***ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Wide Bands | Range Expansion | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
Wide Bands | Range Expansion | -5.05% | |
Oversold Stochastic | Weakness | -5.05% | |
NR7 | Range Contraction | -6.84% | |
Wide Bands | Range Expansion | -6.84% | |
Oversold Stochastic | Weakness | -6.84% | |
Doji - Bullish? | Reversal | -4.72% | |
Wide Bands | Range Expansion | -4.72% | |
Down 3 Days in a Row | Weakness | -4.72% |
Alert | Time |
---|---|
Lower Bollinger Band Support | about 12 hours ago |
Down 5% | about 14 hours ago |
60 Minute Opening Range Breakdown | about 15 hours ago |
Down 3% | about 15 hours ago |
Down 2 % | about 16 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/02/2024
At Travere Therapeutics we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent – that is why our global team works with the rare disease community to identify, develop and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope – today and tomorrow.
Sector: Healthcare
Industry: Drug Manufacturers - Major
Keywords: Medicine Biopharmaceutical Kidney Disease Medical Genetics Dystrophy Muscular Dystrophy Duchenne Muscular Dystrophy Spinal Muscular Atrophy Genetic Genealogy Caregiver Channelopathies Focal Segmental Glomerulosclerosis Glomerulosclerosis
Classification
Sector: Healthcare
Industry: Drug Manufacturers - Major
Keywords: Medicine Biopharmaceutical Kidney Disease Medical Genetics Dystrophy Muscular Dystrophy Duchenne Muscular Dystrophy Spinal Muscular Atrophy Genetic Genealogy Caregiver Channelopathies Focal Segmental Glomerulosclerosis Glomerulosclerosis
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 22.75 |
52 Week Low | 5.25 |
Average Volume | 1,254,102 |
200-Day Moving Average | 9.51 |
50-Day Moving Average | 7.41 |
20-Day Moving Average | 6.56 |
10-Day Moving Average | 6.01 |
Average True Range | 0.39 |
RSI (14) | 23.66 |
ADX | 39.04 |
+DI | 7.78 |
-DI | 36.33 |
Chandelier Exit (Long, 3 ATRs) | 6.96 |
Chandelier Exit (Short, 3 ATRs) | 6.50 |
Upper Bollinger Bands | 7.86 |
Lower Bollinger Band | 5.26 |
Percent B (%b) | 0.07 |
BandWidth | 39.64 |
MACD Line | -0.55 |
MACD Signal Line | -0.47 |
MACD Histogram | -0.0756 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 6.11 | ||||
Resistance 3 (R3) | 6.15 | 5.96 | 6.00 | ||
Resistance 2 (R2) | 5.96 | 5.80 | 5.95 | 5.96 | |
Resistance 1 (R1) | 5.71 | 5.69 | 5.62 | 5.67 | 5.93 |
Pivot Point | 5.52 | 5.52 | 5.48 | 5.51 | 5.52 |
Support 1 (S1) | 5.27 | 5.36 | 5.18 | 5.23 | 4.97 |
Support 2 (S2) | 5.08 | 5.25 | 5.07 | 4.94 | |
Support 3 (S3) | 4.83 | 5.08 | 4.90 | ||
Support 4 (S4) | 4.79 |